Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1
- 3 January 2008
- journal article
- research article
- Published by Wiley in Proteins-Structure Function and Bioinformatics
- Vol. 71 (4) , 1908-1918
- https://doi.org/10.1002/prot.21897
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- H5N1 Influenza — Continuing Evolution and SpreadNew England Journal of Medicine, 2006
- The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug designNature, 2006
- Oseltamivir Resistance — Disabling Our Influenza DefensesNew England Journal of Medicine, 2005
- Anti-influenza virus activity of peramivir in mice with single intramuscular injectionAntiviral Research, 2005
- Avian influenza A (H5N1)Journal of Clinical Virology, 2005
- Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivoBioorganic & Medicinal Chemistry, 2005
- Neuraminidase inhibitors for the treatment and prevention of influenzaExpert Opinion on Pharmacotherapy, 2002
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001
- Resistance of influenza viruses to neuraminidase inhibitors — a reviewAntiviral Research, 2000
- Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvationJournal of the American Chemical Society, 1993